Using financial incentives to increase initial uptake and completion of HPV vaccinations: Protocol for a randomised controlled trial

BMC Health Services Research

Volumn 12, Issue 1, 2012, Pages

  Mantzari, Eleni ^a   Vogt, Florian ^a   Marteau, Theresa M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Financial incentives; HPV; HPV vaccinations; Human papilloma virus; Vouchers

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ANALYSIS OF VARIANCE; ARTICLE; CHI SQUARE DISTRIBUTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECONOMICS; FEMALE; HUMAN; MOTIVATION; PAPILLOMAVIRUS INFECTION; PATIENT ATTITUDE; PREVENTIVE HEALTH SERVICE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SOCIAL EXCLUSION; STATISTICAL MODEL; STATISTICS; UNITED KINGDOM; UTERINE CERVIX TUMOR; VIROLOGY;

ADOLESCENT; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; ENGLAND; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; LOGISTIC MODELS; MOTIVATION; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; SOCIAL MARGINALIZATION; UTERINE CERVICAL NEOPLASMS;

EID: 84865658447     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-12-301     Document Type: Article

References (18)

1. Biological and hormonal markers of chlamydia, human papillomavirus, and bacterial vaginosis among adolescents attending genitourinary medicine clinics. Brabin L, Fairbrother E, Mandal D, Roberts SA, Higgins SP, Chandiok S, Wood P, Barnard G, Kitchener HC, Sex Transm Infect 2005 81 2 128 132 10.1136/sti.2004.010223 15800089
2. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, Darragh TM, Brescia R, Kanowitz S, Miller SB, et al. J Pediatr 1998 132 2 277 284 10.1016/S0022-3476(98)70445-7 9506641
3. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho NS, et al. Lancet 2004 364 9447 1757 1765 10.1016/S0140-6736(04)17398-4 15541448
4. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Villa LL, Costa RLR, Petta CA, Andrade RP, Ault KA, Giuliano AR, Wheeler CM, Koutsky LA, Malm C, Lehtinen M, et al. Lancet Oncol 2005 6 5 271 278 10.1016/S1470-2045(05)70101-7 15863374
5. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GWK, Ferris DG, Steben M, Bryan J, et al. N Engl J Med 2007 356 19 1928 1943 10.1056/NEJMoa061760 17494926
6. Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Widdice LE, Bernstein DI, Leonard AC, Marsolo KA, Kahn JA, Pediatrics 2010 127 1 77 84 21149425
7. Annual HPV vaccine uptake in England: 2008/09. Sheridan A, White J, Barlow T, Soldan K, 2010 http://www.dh.gov.uk/en/Publicationsandstatistics/ Publications/PublicationsPolicyAndGuidance/DH-111675
8. The giants of excess: a challenge to the nation's health. Le Grand J, J R Stat Soc A Stat Soc 2008 171 4 843 856 10.1111/j.1467-985X.2008.00549.x
9. Conditional cash transfers for improving uptake of health interventions in low- and middle-income countries. Lagarde M, Haines A, Palmer N, JAMA 2007 298 16 1900 1910 10.1001/jama.298.16.1900 17954541
10. Health care incentives in immunisation. Achat H, McIntyre P, Burgess M, Aust N Z J Public Health 1999 23 3 285 288 10.1111/j.1467-842X.1999.tb01257.x 10388173
11. Performance-based incentives for health: a way to improve tuberculosis detection and treatment completion? Beith A, Eichler R, Weil D, SSRN eLibr 2007 http://papers.ssrn.com/sol3/papers.cfm?abstract-id=1003247
12. A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users. Seal KH, Kral AH, Lorvick J, McNees A, Gee L, Edlin BR, Drug Alcohol Depend 2003 71 2 127 131 10.1016/S0376-8716(03)00074-7 12927650
13. Impact of targeted financial incentives on personal health behavior: a review of the literature. Sutherland K, Christianson JB, Leatherman S, Med Care Res Rev 2008 65 6-suppl 36S 78 19015378
14. Call for GP incentive on HPV vaccine catch up. Tanday S, GP 2008 http://www.gponline.com/News/article/781981/Call-GP-incentive-HPV-vaccine-catch- up/
15. Using financial incentives to achieve healthy behaviour. Marteau TM, Ashcroft RE, Oliver A, BMJ 2009 338 983 985 10.1136/bmj.b983
16. A measure of informed choice. Marteau TM, Dormandy E, Michie S, Health Expect 2001 4 2 99 108 10.1046/j.1369-6513.2001.00140.x 11359540
17. Increasing influenza immunization among high-risk patients: education or financial incentive? Moran WP, Nelson K, Wofford JL, Velez R, Case LD, Am J Med 1996 101 6 612 620 10.1016/S0002-9343(96)00327-0 9003108
18. Increasing the immunization of preschool children: an evaluation of applied community interventions. Yokley JM, Glenwick DS, J Appl Behav Anal 1984 17 3 313 325 10.1901/jaba.1984.17-313 6439714